Bisphosphonates: use and safety

Guidance on the use and safety of bisphosphonates for bone-related conditions.



This Medicines and Healthcare Products Regulatory Agency (MHRA) guidance for healthcare professionals covers:

  • oesophageal reactions
  • osteonecrosis of the jaw
  • atrial fibrillation
  • atypical femoral fractures
  • adverse effects on renal function

Updates to this page

Published 18 December 2014

Sign up for emails or print this page